Skip to main content

Table 1 Comparison of clinical features between different groups

From: The predictive value of fibrinogen in the occurrence of mild cognitive impairment events in patients with diabetic peripheral neuropathy

Group

Healthy control

P value1

Diabetes without neuropathy

P value2

Diabetes with neuropathy

P value3

Case (male/female)

48/42

0.723

57/45

0.791

54/51

0.521

Age (years)

51.3 ± 8.0

0.749

51.0 ± 9.4

0.750

51.7 ± 7.3

0.509

Disease course (years)

5.5 ± 3.2

7.9 ± 3.8

0.000

Smoking (N/Y)

59/31

0.871

68/34

0.024

52/53

0.012

Education level (years)

9.9 ± 2.9

0.775

9.7 ± 2.9

0.401

9.5 ± 3.0

0.568

SBP (mmHg)

122 ± 7

0.091

124 ± 9

0.365

123 ± 10

0.410

DBP (mmHg)

70 ± 6

0.910

70 ± 8

0.988

70 ± 6

0.894

BMI (kg/m 2)

24.4 ± 1.5

0.490

24.5 ± 1.5

0.670

24.5 ± 1.4

0.781

FPG (mmol/L)

4.7 ± 0.5

0.000

8.2 ± 1.3

0.000

8.2 ± 1.5

0.928

HbA1c (%)

4.8 ± 0.4

0.000

7.7 ± 1.2

0.000

8.8 ± 1.9

0.000

TC (mmol/L)

4.8 ± 0.6

0.297

4.9 ± 0.6

0.196

4.8 ± 0.8

0.800

LDL-C (mmol/L)

2.6 ± 0.7

0.430

2.7 ± 0.7

0.616

2.7 ± 0.9

0.762

HDL-C (mmol/L)

1.3 ± 0.3

0.243

1.3 ± 0.4

0.285

1.3 ± 0.4

0.913

ALT (IU/L)

24 ± 4

0.831

24 ± 3

0.458

24 ± 2

0.586

AST (IU/L)

22 ± 4

0.892

22 ± 3

0.346

21 ± 4

0.265

Vit B12 (pmol/L)

531 ± 169

0.933

534 ± 196

0.590

546 ± 206

0.638

UACR (mg/g)

21.4 ± 2.8

0.594

21.6 ± 3.3

0.962

21.4 ± 2.8

0.613

eGFR [ml/(min·1.73m2)]

126.8 ± 38.5

0.387

122.5 ± 27.3

0.277

121.4 ± 36.5

0.823

Fib(g/L)

2.98 ± 0.58

0.400

3.06 ± 0.51

0.000

4.38 ± 0.83

0.000

  1. 1P, healthy control vs. diabetes without neuropathy. 2P, healthy control vs. diabetes with neuropathy. 3P, diabetes without neuropathy vs. diabetes with neuropathy